MONEY

Equillium CFO Jason Keyes sells $8,100 in company stock

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 28, 2024 - 08:00
Equillium CFO Jason Keyes sells $8,100 in company stock
Read More

Tags:

Previous Article

Over 3.5 million customers without power in US southeast from Helene

Next Article

Janux therapeutics executive sells $2.3 million in stock

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

IMPLANET Announces Its 2024 Half-year Results

IMPLANET Announces Its 2024 Half-year Results

Tomas Kauer - Mode... Sep 11, 2024

Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab

Junshi Biosciences Announces European Commission Approv...

Tomas Kauer - Mode... Sep 25, 2024

IMFINZI ® (durvalumab) perioperative regimen reduced the risk of recurrence by 32% and the risk of death by 25% vs. neoadjuvant chemotherapy alone in muscle-invasive bladder cancer in the NIAGARA Phas

IMFINZI ® (durvalumab) perioperative regimen reduced th...

Tomas Kauer - Mode... Sep 16, 2024